254 related articles for article (PubMed ID: 27857060)
21. Screening Driving Transcription Factors in the Processing of Gastric Cancer.
Xu G; Li K; Zhang N; Zhu B; Feng G
Gastroenterol Res Pract; 2016; 2016():8431480. PubMed ID: 27403158
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive transcriptomic landscape of cholangiocarcinoma based on bioinformatics analysis from large cohort of patients.
Li H; Qu L; Zhang H; Liu J; Zhang X
Sci Rep; 2021 Jul; 11(1):13713. PubMed ID: 34211100
[TBL] [Abstract][Full Text] [Related]
23. Integrated microarray analysis provided novel insights to the pathogenesis of glaucoma.
Wang J; Qu D; An J; Yuan G; Liu Y
Mol Med Rep; 2017 Dec; 16(6):8735-8746. PubMed ID: 28990066
[TBL] [Abstract][Full Text] [Related]
24. Identification of key transcription factors in caerulein-induced pancreatitis through expression profiling data.
Qi D; Wu B; Tong D; Pan Y; Chen W
Mol Med Rep; 2015 Aug; 12(2):2570-6. PubMed ID: 25975747
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional Regulatory Network Analysis for Gastric Cancer Based on mRNA Microarray.
Wang Y
Pathol Oncol Res; 2017 Oct; 23(4):785-791. PubMed ID: 28078605
[TBL] [Abstract][Full Text] [Related]
26. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
27. Integrative analysis of transcriptional regulatory network and copy number variation in intrahepatic cholangiocarcinoma.
Li L; Lian B; Li C; Li W; Li J; Zhang Y; He X; Li Y; Xie L
PLoS One; 2014; 9(6):e98653. PubMed ID: 24897108
[TBL] [Abstract][Full Text] [Related]
28. Identification of differentially expressed genes and their upstream regulators in colorectal cancer.
Liu HY; Zhang CJ
Cancer Gene Ther; 2017 Jun; 24(6):244-250. PubMed ID: 28409560
[TBL] [Abstract][Full Text] [Related]
29. Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray.
Xie W; Ji L; Zhao T; Gao P
Med Sci Monit; 2015 May; 21():1333-44. PubMed ID: 25957414
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
31. Identification of human prolactinoma related genes by DNA microarray.
Zhao L; Lin M; Wang S
J Cancer Res Ther; 2014; 10(3):544-8. PubMed ID: 25313736
[TBL] [Abstract][Full Text] [Related]
32. Meta-Analysis of Transcriptome Regulation During Induction to Cardiac Myocyte Fate From Mouse and Human Fibroblasts.
Rastegar-Pouyani S; Khazaei N; Wee P; Yaqubi M; Mohammadnia A
J Cell Physiol; 2017 Aug; 232(8):2053-2062. PubMed ID: 27579918
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
34. Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes.
Han BW; Ye H; Wei PP; He B; Han C; Chen ZH; Chen YQ; Wang WT
BMC Genomics; 2018 Oct; 19(1):735. PubMed ID: 30305026
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
Wang Z; Du Y
Int Immunopharmacol; 2021 Oct; 99():108039. PubMed ID: 34426102
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
Liu J; Li J; Li H; Li A; Liu B; Han L
Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics analysis of gene expression data for the identification of critical genes in breast invasive carcinoma.
Li Y; Wang Y
Mol Med Rep; 2017 Dec; 16(6):8657-8664. PubMed ID: 28990063
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
39. Expressional and prognostic value of HPCAL1 in cholangiocarcinoma via integrated bioinformatics analyses and experiments.
Ma M; Zeng G; Li J; Liang J; Huang L; Chen J; Lai J
Cancer Med; 2023 Jan; 12(1):824-836. PubMed ID: 35645147
[TBL] [Abstract][Full Text] [Related]
40. Revealing gene clusters associated with the development of cholangiocarcinoma, based on a time series analysis.
Wu J; Xiao Z; Zhao X; Wu X
Mol Med Rep; 2015 May; 11(5):3481-6. PubMed ID: 25606976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
